08.03.2018 • News

Catalent Completes Expansion at Singapore Facility

Catalent Pharma Solutions has completed the $4.6 million expansion at its Singapore clinical supply facility, announced in Feb. 2016. The New Jersey, USA-based company said the expansion provides additional GMP space for secondary packaging, has doubled ambient storage, and quadrupled cold storage capacity at the site.

The facility is a key strategic hub in Catalent’s Asia-Pacific network and global clinical supply business, supporting multinational customers’ growing needs for full clinical supply services, while providing flexible solutions for local customers in the region.

According to Catalent the site has seen significant growth since opening in 1998, almost tripling in size and now standing at almost 20,000 square feet, with headcount also tripling since 2012.

“We are particularly pleased to have completed the expansion in a year that marks the 20th anniversary of what was Catalent’s first facility in the Asia-Pacific region,” commented Bernie Clark, VP marketing, Catalent Clinical Supply Services. He added: “Supported by many long-serving employees, the Singapore site has undergone tremendous growth over the past two decades and now routinely distributes to 18 countries in the region.”

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.